Assessment of Carboplatin Clearance Predictors: A PK Study on NCI-sponsored Clinical Trials or Standard of Care Treatments Using Carboplatin
Principal Investigator
Sarah Taylor,
Status
Open to Accrual
Date Opened To Accrual
November 18 2019
Disease Site
Gynecologic [GY]
Other
Phase
I
Developmental Therapeutics
No
Primary Objective
Evaluate the success of targeting a carboplatin AUC with our current approach to dosing carboplatin.
Patient Population
Any patients who will receive treatment with intravenous carboplatin (any AUC, any cycle) on an NCI-sponsored NCTN-, ETCTN-, trial, local trial, or through standard of care.
Target Accrual
250
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.